I et klinisk forsøg med forsøgspersoner, der har mild, moderat, svær eller end- stage (dialyseafhængig) nedsat nyrefunktion var anidulafungins farmakokinetik den samme som hos forsøgspersoner med normal nyrefunktion.
In a clinical study of subjects with mild, moderate, severe or end stage (dialysis-dependent) renal insufficiency, anidulafungin pharmacokinetics were similar to those observed in subjects with normal renal function.